Gilead Sciences to buy Cell Design Labs for $567 million


On Dec. 7, 2017, Gilead Sciences and its cell-therapy subsidiary Kite Pharma announced an agreement to acquire Cell Design Labs, a pre-clinical stage biotherapeutics company specializing in custom cell engineering.

In August, Novartis AG's Kymriah became the first CAR-T cell therapy to get US approval, signaling a new era in the treatment of cancer.

The Cell Design acquisition could expand Gilead's cell therapy capabilities beyond cancer. He is also Cell Design Labs' scientific founder as well as an investigator with the Howard Hughes Medical Institute. The company's lead preclinical compound targets multiple myeloma.

"Cell Design Labs' talented team of cell biology experts will augment and accelerate our work to bring forward new generations of CAR-T and T-cell receptor (TCR) therapies, building on our acquisition of Kite earlier this year and our efforts to improve care for people with advanced cancers", Gilead president and CEO John F. Milligan, Ph.D., said in a statement. Under the terms of the deal, Gilead will initially pay about $175 million and dole out the remaining $322 million to CDL shareholders, other than Kite, following the achievement of certain.

Emeryville, CA-based Cell Design Labs is based on the research of University of California, San Francisco, scientist Wendell Lim.

Throttle, on the other hand, is an on switch that modulates vehicle T activity using small molecules.

Cell Design is a logical next step.

Cell Design Labs is developing several preclinical product candidates, including therapies for prostate cancer and hepatocellular carcinoma that use the synNotch technology. The company says that these technologies are able to engineer cells that are better able to recognize cancer, and in turn, spare healthy tissue.

"This acquisition demonstrates our deep commitment to continuing to invest in future innovation in the field of cellular therapy, both internally and externally", said Gilead CEO John Milligan in a December 7 statement. That's significant because the Kite CAR-T, which was approved to treat cases of non-Hodgkin lymphoma in patients who had failed two other treatments, comes with the risk of an immune response called cytokine release syndrome, in which inflammatory proteins called cytokines are activated in the body.



Related Posts

BB&T Corporation (BBT) Shares Sold by Stifel Financial Corp
By 23.24% BB&T Corporation EPS 23.24% will be on a par with past year, analyst expect per share earnings to be lower by 23.24%. The firm owned 93,686 shares of the insurance provider's stock after acquiring an additional 16,421 shares during the quarter.

Argentina beat India in Hockey World League Final semis
With this, Argentina, with the score being 1-0 against India, managed to reach their first ever final at the Hockey World League. The Indian coach, who generally watches re-runs of matches his side plays, said he wouldn't bother looking at this one.

Feds probe Cuomo over hiring practices
Cuomo did reduce his personnel budget by 10 percent - $600,000 - he did not cut the number of employees who report to him. Federal Bureau of Investigation spokespeople in Albany and Washington declined comment as did a spokesman for the U.S.

Yankees, Brian Cashman close to new, five-year deal
The 50-year-old Cashman has been part of the Yankees organization since 1986, and he was promoted to general manager in 1998. The deal would give Cashman a significant raise, as his three-year, $9 million deal expired after the 2017 season.

Report says county has nation's fourth-largest homeless populaton
Across the country, city leaders and advocates are scrambling to find a way to end-or at least reduce-homelessness. Louisiana's population has declined by over 17 percent in the past year , according to a new report from the U.S.

What Analysts Have to Say About Ensco Plc (ESV)?
However, at one point, in the middle of the day, the price touched a high of $25.41 before it finally returned some of the gains. For the current quarter Ensco Plc (NYSE: ESV ) has high EPS estimates of $-0.02 in contradiction of low EPS estimates of $-0.6.

Al Franken Victim Leeann Tweeden Responds to Democrat's Resignation
She also said she's been the target of "vile and partisan personal attacks" since she disclosed the incidents with Franken . Tim Pawlenty could run for the same seat he planned to seek 15 years ago.

Stock Trending Alert: Blackstone Mortgage Trust, Inc. (BXMT)
The firm has "Sector Perform" rating by FBN Securities given on Monday, October 10. (NYSE:CLF) to report earnings on February, 8. Moreover, Susquehanna International Group Limited Liability Partnership has 0% invested in Blackstone Mortgage Trust, Inc .

Quantbot Technologies LP Buys New Holdings in MGIC Investment Corporation (MTG)
Moreover, Westfield Management Ltd Partnership has 0.4% invested in MGIC Investment Corporation (NYSE: MTG ) for 4.24M shares. Jane Street Gru Ltd Limited Liability Company owns 0% invested in MGIC Investment Corporation (NYSE: MTG ) for 31,969 shares.

Fake education board busted
During the course of investigation, it was found that one Parshant Solanki had given the said fake marksheet to the complainant. At his instance, Baljeet Singh, who was looking after the work of Director of Board in the absence of Mange Ram Acharya.

© 2015 ExpressNewsline. All Rights reserved.